BEIJING, June 21, 2024 /PRNewswire/ — 36Kr Holdings Inc. (“36Kr” or the “Company”) (NASDAQ: KRKR), a prominent brand and pioneering platform dedicated to serving New Economy participants in China, today announced that it has entered into a strategic partnership with SenseTime, a leading global artificial intelligence (AI) software company, to embed Artificial General Intelligence (“AGI”) technology […]
Category Archives: Pr Newswire
CASTRES, France, June 21, 2024 /PRNewswire/ — Pierre Fabre Laboratories has been awarded the “Prix Galien International” Prize in the “Best Product for a Rare/Orphan Disease” category for EBVALLO® (tabelecleucel), indicated as monotherapy for the treatment of patients with post-transplant lymphoproliferative disorder positive for Epstein-Barr virus (EBV+ PTLD) who have received at least one prior treatment. […]
GUELPH, ON, June 21, 2024 /PRNewswire/ — Canadian Solar Inc. (the “Company” or “Canadian Solar”) (NASDAQ: CSIQ), today announced that it held its Annual Meeting of Shareholders on June 21, 2024. Each of the proposals submitted for shareholder approval was approved. Specifically, the shareholders approved: The election of Shawn (Xiaohua) Qu, Harry E. Ruda, Lauren C. […]
MUNICH, June 21, 2024 /PRNewswire/ — From June 19th to 21st, Goldwind Carbon Neutral, a wholly-owned subsidiary of Goldwind Science & Technology Co., Ltd., the world’s largest wind turbine manufacturer, participated in The smarter E Europe 2024 (TSEE) in Munich, Germany. During the event, Goldwind Carbon Neutral signed strategic cooperation agreements with several global energy […]
All dollar amounts reflected in Canadian dollars unless otherwise stated VANCOUVER, British Columbia, June 20, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies, is pleased to announce, further to the press release dated May 23, 2024, that […]
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today the publication of a manuscript in Scientific Reports, demonstrating how three key factors can be determinant for efficient TALE base […]
NOVATO, Calif., June 20, 2024 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 45,525 restricted stock units of the company’s common stock to 26 newly hired non-executive officers of the company. The awards […]
BELTSVILLE, Md., June 20, 2024 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies, today announced that it will present and host institutional investor meetings at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on Thursday, June 27, 2024. A recording of […]
Brain Canada and Brain Changes Initiative (BCI) to support innovative projects that will address some of the most pressing issues in TBI MONTREAL, June 20, 2024 (GLOBE NEWSWIRE) — It is estimated that approximately 165,000 people per year experience a traumatic brain injury (TBI) in Canada, and that by 2031, TBI is projected to be […]
Hyundai Motor Group (the Group) hosts a technical seminar at Cannes Lions 2024 under the theme ‘From Logic to Magic: 5 Ways to Make Tech Resonate’ The seminar highlights Nano Cooling Film and Hyundai Motor’s recent ‘Made Cooler By Hyundai’ campaign, demonstrating its commitment to addressing social issues with advanced technology Cannes Lions Festival showcases top […]
